EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Optimization and Investigation of Hemoglobin‐Loaded ZIF‐90 Metal–Organic Framework Nanoparticles as Artificial Oxygen Carriers

Despoina Douka, Weiguang Jin, Carlos Cantallops‐Iglesias, Arnau Dieste‐Izquierdo, Peter Waaben Thulstrup, Leticia Hosta‐Rigau

Particle & Particle Systems Characterization · 2025-03 · 42 (3)

DOI: 10.1002/ppsc.202400189 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Particle & Particle Systems Characterization, online erschienen am 22.10.2024. Verfasst von Despoina Douka und 5 weiteren Autor:innen. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: H2020 European Research Council.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Blood transfusions are vital, yet limited shelf‐life and storage conditions of red blood cells (RBCs) hinder their use in emergencies. Hemoglobin‐based oxygen carriers (HBOCs) aim to address these challenges, but previous versions faced clinical setbacks due to safety concerns related to hemoglobin (Hb) extravasation. ZIF‐90, a novel metal–organic framework variant where imidazole‐2‐carboxaldehyde (2‐ICA) is bridged to Zn 2+ ions, is explored. Optimizing Zn 2+ :2‐ICA ratios and Hb concentrations, Hb‐loaded ZIF‐90 nanoparticles (NPs) are synthesized in one‐step and under mild synthesis conditions. These NPs achieve a 25.1% yield, 7.0 mg mL −1 Hb concentration, 70.3% encapsulation efficiency (EE), and 96.4% drug loading. They exhibit a left‐shifted oxygen dissociation curve with p50 of ≈8 mmHg, indicating enhanced oxygen release at lower partial oxygen pressures as compared to native RBCs. This feature makes Hb‐loaded ZIF‐90 NPs suitable for certain medical applications including ischemia‐reperfusion injury management. Furthermore, the impact of two prominent capping agents: polyvinylpyrrolidone and polyethylene glycol (PEG) is assessed. PEG improves 2‐ICA incorporation and stabilizes the ZIF‐90 crystalline phase, albeit with reduced yield, Hb content, and EE. The findings underscore the potential of Hb‐loaded ZIF‐90 NPs as next‐generation HBOCs, offering enhanced uniformity, high Hb content, and efficient oxygen binding and release properties for medical applications.

Förderung

  • H2020 European Research Council

Zitieren

APA

Douka, D., Jin, W., Cantallops‐Iglesias, C., Dieste‐Izquierdo, A., Thulstrup, P. W., & Hosta‐Rigau, L. (2025). Optimization and Investigation of Hemoglobin‐Loaded ZIF‐90 Metal–Organic Framework Nanoparticles as Artificial Oxygen Carriers. Particle & Particle Systems Characterization, 42(3). https://doi.org/10.1002/ppsc.202400189

Vancouver

Douka D, Jin W, Cantallops‐Iglesias C, Dieste‐Izquierdo A, Thulstrup PW, Hosta‐Rigau L. Optimization and Investigation of Hemoglobin‐Loaded ZIF‐90 Metal–Organic Framework Nanoparticles as Artificial Oxygen Carriers. Particle & Particle Systems Characterization. 2025;42(3). doi:10.1002/ppsc.202400189

BibTeX
@article{Douka2025,
  author = {Douka, Despoina and Jin, Weiguang and Cantallops‐Iglesias, Carlos and Dieste‐Izquierdo, Arnau and Thulstrup, Peter Waaben and Hosta‐Rigau, Leticia},
  title = {Optimization and Investigation of Hemoglobin‐Loaded ZIF‐90 Metal–Organic Framework Nanoparticles as Artificial Oxygen Carriers},
  journal = {Particle & Particle Systems Characterization},
  year = {2025},
  volume = {42},
  number = {3},
  doi = {10.1002/ppsc.202400189}
}
Kostenlos starten →